Research Paper (479)

  • CDKN2A Mutation: A Patient’s and Physician’s Experience
    CDKN2A Mutation: A Patient’s and Physician’s Experience

    Yaelle Shaked

    Get Access
  • Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
    Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata

    Arash Mostaghimi

    Get Access
  • Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape
    Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape

    Savanna I. Vidal

    Get Access
  • Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
    Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study

    Federico Diotallevi

    Get Access
  • Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months
    Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

    Diamant Thaçi

    Get Access
  • Demographics and Clinical Characteristics among Patients with Distinct Psychosocial Burden Profiles Related to Vitiligo: Results of a Latent Class Analysis
    Demographics and Clinical Characteristics among Patients with Distinct Psychosocial Burden Profiles Related to Vitiligo: Results of a Latent Class Analysis

    Kent A. Hanson

    Get Access
  • Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study
    Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study

    Federico Diotallevi

    Get Access
  • Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa Patient
    Severe Paradoxical Scalp Psoriasis Induced by Bimekizumab in a Young Multifailure Hidradenitis Suppurativa Patient

    Fabrizio Martora

    Get Access
  • Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
    Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events

    Mark Lebwohl

    Get Access
  • Risk of Superficial Fungal Infections in WHIM Syndrome
    Risk of Superficial Fungal Infections in WHIM Syndrome

    Jennifer Strong

    Get Access
  • An Effective and Safe Laser Treatment Strategy of Fractional Carbon Dioxide Laser for Chinese Populations with Periorbital Wrinkles: A Randomized Split-Face Trial
    An Effective and Safe Laser Treatment Strategy of Fractional Carbon Dioxide Laser for Chinese Populations with Periorbital Wrinkles: A Randomized Split-Face Trial

    Xianglei Wu

    Get Access
  • Alopecia Areata Incognita: Current Evidence
    Alopecia Areata Incognita: Current Evidence

    Giselle Rodríguez-Tamez

    Get Access
  • Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients
    Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients

    Michela Starace

    Get Access
  • Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials
    Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials

    John R. Ingram

    Get Access
  • Analysis of PEST Questionnaire Responses in Patients with Psoriasis in Daily Practice: Results from a Single-Center of Psoriasis in the Czech Republic
    Analysis of PEST Questionnaire Responses in Patients with Psoriasis in Daily Practice: Results from a Single-Center of Psoriasis in the Czech Republic

    Simona Tivadar

    Get Access
  • Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview
    Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview

    John R. Ingram

    Get Access
  • Treating Generalized Pustular Psoriasis (GPP): Timing and Rationale for Biologic Treatment Switching—A Japanese e-Delphi Survey
    Treating Generalized Pustular Psoriasis (GPP): Timing and Rationale for Biologic Treatment Switching—A Japanese e-Delphi Survey

    Yayoi Tada

    Get Access
  • Efficacy, Safety, and Cost-effectiveness of Zinc Oxide Nanoparticles in Whitfield’s Spirit Solution for Treating Superficial Fungal Foot Infections: A Randomized Controlled Trial
    Efficacy, Safety, and Cost-effectiveness of Zinc Oxide Nanoparticles in Whitfield’s Spirit Solution for Treating Superficial Fungal Foot Infections: A Randomized Controlled Trial

    Charussri Leeyaphan

    Get Access
  • Mental Health and Psychosocial Burden Among Patients with Skin of Color Living with Vitiligo: Findings from the Global VALIANT Study
    Mental Health and Psychosocial Burden Among Patients with Skin of Color Living with Vitiligo: Findings from the Global VALIANT Study

    Pearl Grimes

    Get Access
  • Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity
    Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity

    Michael Gold

    Get Access
  • Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
    Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD

    Pedro Mendes-Bastos

    Get Access
  • Bioactives for Estrogen-Deficient Skin: Topical and Oral Supplement Clinical Studies. A Narrative Review
    Bioactives for Estrogen-Deficient Skin: Topical and Oral Supplement Clinical Studies. A Narrative Review

    Edwin D. Lephart

    Get Access
  • Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
    Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE

    Jonathan I. Silverberg

    Get Access
  • The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal
    The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal

    Bruno Duarte

    Get Access
  • Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies
    Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical Therapies

    Melinda J. Gooderham

    Get Access
  • Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis
    Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis

    Alzahra A. Mohammed

    Get Access
  • Correction: Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Correction: Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

    Tiago Torres

    Get Access
  • Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation
    Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation

    Katharina Hogrefe

    Get Access
  • Management of Challenging Psoriasis Clinical Scenarios
    Management of Challenging Psoriasis Clinical Scenarios

    Linda Stein Gold

    Get Access
  • Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis
    Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis

    Sonja Ständer

    Get Access

Your Feedback